You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - prognosis, predictors and outcome
AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry

 

Online download statistics by month:

Online download statistics by month: June 2014 to February 2024

AbstractFullPdf
Jun 2014200
Jul 2014200
Aug 2014801
Sep 20141902
Oct 2014800
Nov 2014900
Dec 2014301
Jan 2015700
Feb 20151104
Mar 20151201
Apr 2015500
May 2015401
Jun 20151000
Jul 20151701
Aug 2015701
Sep 2015301
Nov 2015302
Jan 2016300
Feb 2016400
Mar 2016201
Apr 2016700
May 2016200
Jun 201610014
Jul 2016800
Aug 2016500
Sep 2016801
Oct 20161001
Nov 2016500
Dec 2016600
Jan 2017700
Feb 2017300
Mar 20171000
Apr 2017500
May 2017400
Jun 2017400
Jul 2017600
Aug 20171200
Sep 2017800
Oct 2017800
Nov 2017400
Dec 20171000
Jan 2018800
Mar 2018800
Apr 2018600
May 20184801
Jun 2018600
Jul 2018600
Aug 2018600
Sep 2018400
Oct 2018400
Nov 2018400
Dec 2018600
Jan 2019400
Feb 2019200
Apr 2019200
Jul 2019200
Dec 2019200
Jul 2020200
Sep 2020800
Oct 2020800
Nov 2020200
Dec 2020400
Jan 2021200
Feb 2021600
Nov 2021400
Dec 2021600
Feb 2022400
Apr 2022200
May 2022200
Jul 20226801
Aug 20221000
Sep 2022200
Oct 2022200
Nov 2022400
Dec 2022800
Jan 2023800
Feb 2023600
Mar 2023200
May 2023200
Jul 2023200
Aug 2023400
Sep 2023400
Dec 20231000
Feb 2024400
Total585034